Ignite Creation Date:
2025-12-24 @ 9:48 PM
Ignite Modification Date:
2026-03-29 @ 5:44 PM
Study NCT ID:
NCT05949632
Status:
TERMINATED
Last Update Posted:
2025-08-03
First Post:
2023-07-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors
Sponsor:
Incyte Corporation
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Solid Tumors | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | gynecologic tract cancer | View |
| None | ovarian cancer | View |
| None | primary peritoneum cancer | View |
| None | fallopian tube cancer | View |
| None | uterine cancer | View |
| None | cervical cancer | View |
| None | vulvar cancer | View |
| None | vaginal cancer | View |
| None | clear cell histology | View |
| None | mucinous adenocarcinoma | View |
| None | carcinosarcoma | View |
| None | serous adenocarcinoma | View |
| None | neuroendocrine histology | View |
| None | small cell histology | View |
| None | small-molecule pdl1 inhibitor | View |
| None | tyrosine kinase inhibitor | View |
| None | combination therapy | View |